Between 2010 and 2019, Cancer Incidence Among Americans Under 50 Increased Overall, With the Steepest Rises in the 30 to 39 Age Group. Gastrointestinal Cancers Drove the Fastest Growth.

Cancer has long been understood as a disease of aging. The biological logic is intuitive: more years of cellular replication, more accumulated DNA damage, higher cumulative exposure to carcinogens. What this cohort study from researchers across the United States and Singapore documents is a meaningful departure from that pattern. Among adults under 50, overall cancer incidence increased during the study period, the increases were sharpest in the youngest subgroups examined, and gastrointestinal cancers, which have known and modifiable risk factors, led the rise. These findings have direct implications for screening guidelines, clinical vigilance, and public health priorities.

Koh et al. conducted a population-based cohort study using data from 17 National Cancer Institute Surveillance, Epidemiology, and End Results registries covering January 1, 2010 through December 31, 2019. Age-standardized incidence rates per 100,000 people were calculated for early-onset cancers, defined as cancers diagnosed in people younger than 50 years. A total of 562,145 patients with early-onset cancer were identified and included. The annual percentage change (APC) of the age-standardized incidence rate was estimated using the Joinpoint regression program, the same methodology used in the National Cancer Institute's own trend analyses. Rates and APCs were stratified by sex, race and ethnicity, and age group, specifically 0 to 19 years, 20 to 29 years, 30 to 39 years, and 40 to 49 years.

From 2010 to 2019, the overall age-standardized incidence rate of early-onset cancers increased significantly (APC 0.28%, 95% CI 0.09% to 0.47%, P = 0.01). The increase was driven primarily by female individuals (APC 0.67%, 95% CI 0.39% to 0.94%, P = 0.001), while incidence decreased in male individuals over the same period. The largest increases were observed in the 30 to 39 age group. Breast cancer had the highest number of incident cases in 2019 among all early-onset cancers. Gastrointestinal cancers, including colorectal, appendiceal, and small intestinal cancers, had the fastest-growing incidence rates of any cancer category. Among all cancer types, thyroid cancer had the highest age-standardized incidence rate. The racial and ethnic breakdown of the 562,145 patients was 56.0% White, 21.0% Hispanic, 10.9% Black, 9.8% Asian or Pacific Islander, 0.8% American Indian or Alaska Native, and 1.6% of unknown race and/or ethnicity.

• —The study covers 2010 to 2019 and does not capture the potential disruptions to cancer diagnosis rates during the COVID-19 pandemic, when screening and diagnostic procedures were significantly delayed across the United States.
• —Surveillance, Epidemiology, and End Results registries, while comprehensive, do not cover the entire United States population, which may introduce geographic selection bias.
• —The study characterizes incidence trends but does not establish causation. The drivers of increasing early-onset cancer rates require separate mechanistic and epidemiological investigation.
• —Racial and ethnic subgroup analyses may be limited by sample sizes in smaller groups, particularly American Indian and Alaska Native populations, for whom the analysis was restricted to areas with Indian Health Services coverage.

Cancer among adults under 50 is increasing in the United States, particularly among women and particularly in the gastrointestinal tract. The pattern is not explained by improved detection alone. It tracks closely with population-level changes in diet, obesity, and metabolic health that have accelerated across younger generations. Clinicians should maintain a lower threshold for investigating gastrointestinal symptoms in younger patients than historical norms might suggest, and the screening age debate for colorectal cancer in average-risk individuals is not settled.